Latest filing published 03 Mar 2023 for OptimizeRx Corp, €3,989.
Insider track record
No signal scores available.
Todd Inman: trading record in brief
Todd Inman is a declared insider of OptimizeRx Corp, with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 1 March 2023, with 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 March 2023 came the latest disclosure, a share grant for €3,989 in OptimizeRx Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Todd Inman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 233 shares@ US$18.11100.0% of flowCommon StockSEC:0001628280-23-006252:1
- 771 shares0Common StockSEC:0001628280-23-006252:0
2 of 2 declarations
